[Federal Register Volume 65, Number 100 (Tuesday, May 23, 2000)]
[Notices]
[Pages 33353-33354]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-12842]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 14, 2000, and published in the Federal 
Register on February 22, 2000, (65 FR 35), Isotec Inc., 3858 Benner 
Road, Miamisburg, Ohio 45342, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                     Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).............................  I
Methcathinone(1237)..........................  I
N-Ethylamphetamine (1475)....................  I
N-N-Dimethylamphetamine (1480)...............  I
Aminorex (1585)..............................  I
Methaqualone (2565)..........................  I
Lysergic acid diethylamide (7315)............  I
Tetrahydrocannabinols (7370).................  I
Mescaline (7381).............................  I
2,5-Dimethoxyamphetamine (7396)..............  I
3,4-Methylenedioxyamphetamine (7400).........  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).  I
3, 4,-Methylenedioxymethamphetamine (7405)...  I
4-Methoxyamphetamine (7411)..................  I
Psilocybin (7437)............................  I
Psilocyn (7438)..............................  I
N-Ethyl-1-phenylcyclohexylamine (7455).......  I
Dihydromorphine (9145).......................  I
Normorphine (9313)...........................  I
Acetylmethadol (9601)........................  I
Alphacetylmethadol Except Levo-                I
 Alphacetylmethadol (9603).
Normethadone (9635)..........................  I
3-Methylfentanyl (9813)......................  I
Amphetamine (1100)...........................  II
Methamphetamine (1105).......................  II
Methylphenidate (1724).......................  II
Amobarbital (2125)...........................  II
Pentobarbital (2270).........................  II
Secobarbital (2315)..........................  II
1-Phenylcyclohexylamine (7460)...............  II
Phencyclidine (7471).........................  II
Phenylacetone (8501).........................  II
1-Piperidinocyclohexanecarbonitrile (8603)...  II
Codeine (9050)...............................  II
Dihydrocodeine (9120)........................  II
Oxycodone (9143).............................  II
Hydromorphone (9150).........................  II
Benzoylecgonine (9180).......................  II

[[Page 33354]]

 
Ethylmorphone (9190).........................  II
Hydrocodone (9193)...........................  II
Isomethadone (9226)..........................  II
Meperidine (9230)............................  II
Methadone (9250).............................  II
Methadone intermediate (9254)................  II
Dextropropoxyphene, bulk (non-dosage forms)    II
 (9273).
Morphine (9300)..............................  II
Levo-Alphacetylmethadol (9648)...............  II
Oxymorphone (9652)...........................  II
Fentanyl (9801)..............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to produce standards for analytical laboratories.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Iostec, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated the company on a 
regular basis to ensure that its continued registration is consistent 
with the public interest. These investigations have included inspection 
and testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: May 12, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-12842 Filed 5-22-00; 8:45 am]
BILLING CODE 4410-09-M